Zinc, Iron, Vitamin A and Psychosocial Care for Child Growth and Development

December 13, 2014 updated by: Umi Fahmida, Indonesia University

Zinc, Iron and Vitamin A Supplementation for Infant Growth and Development, and the Contributing Role of Psychosocial Care

Many Indonesian infants are already iron deficient before they reach the age of six months, which also determines the high prevalence of anemia among under-five children. Iron deficiency ultimately leads to anemia, and there is clear evidence that iron deficiency anemia during early childhood has a marked negative effect on child development and cognitive function (Lozoff et al.1991; Idjradinata & Pollitt, 1993). This negative impact on childhood development is one of the main reasons why iron deficiency during infancy should be prevented or treated.

Since diets low in iron is usually also low in zinc, zinc deficiency --which has negative consequence on growth-- is common in iron deficiency area. In Southeast Asia, the condition is exacerbated by the rich phytate content in the complementary foods which inhibits the absorption of iron as well as zinc (Gibson, 1994). Thus, combining both iron and zinc, hence, is expected to decrease both iron and zinc deficiencies and hence improve growth and development of the children.

Recently, there has been an emerging view which looks at the two-way relationship between nutrition, health, and psychosocial well-being. This concept is supported by studies on "positive deviance", a term used to refer to children who grow and develop well in impoverished environments where most children are victims of malnutrition and chronic illness (Zeitlin et al., 1990). The mechanism which helps to explain how psychosocial factors, such as the affect between mother and child, are associated with adequate growth and development: 'Psychological stress has a negative effect on the use of nutrients whereas psychological well-being stimulates the secretion of growth-promoting hormones. Pleasantly stimulating interactions can enhance the child's tendency to exercise its developing organ systems and hence to utilize nutrients for growth and development'.

Understanding how the psychosocial environment can promote or inhibit the benefit of supplementation intervention is necessary in order to have a better way of setting about providing supplements. In fact, many supplementation programs do not incorporate complementary program elements that would help to improve the health and psychosocial development of children at the same time that they improve nutritional status' (Myers, 1995). Looking from this perspective, not only will supplementation benefit the psychosocial development but also the psychosocial environment can promote the benefit of the supplementation on the nutritional status and developmental outcomes of infants.

The purpose of the study is to investigate whether multi-micronutrient supplementations (zinc+iron, zinc+iron+vit.A) have positive effect on infants' growth and developmental outcomes, and whether the effect is modified by psychosocial care.

Study Overview

Study Type

Interventional

Enrollment (Actual)

800

Phase

  • Phase 3

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Java
      • Jakarta, Java, Indonesia, 10430
        • South East Asian Ministers of Education Organization, Regional Center for Food and Nutrition (SEAMEO-RECFON)

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

3 months to 6 months (Child)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • 3 to 6 month old
  • predominantly breast-fed children (assuming the infants were already introduced complementary feedings as early as 4 months)
  • parental consent

Exclusion Criteria:

  • apparent congenital abnormalities

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Zinc Alone
Zinc Sulphate (10 mg Zn/day)
Zn-alone group received 10 mg/day of elemental zinc (as zinc sulphate)
Experimental: Iron and Zinc
Ferrous Sulphate and Zinc Sulphate (10 mg/day of each zinc and iron)
Zn+Fe group received 10 mg/day of elemental zinc (as zinc sulphate) and 10 mg/day of elemental iron (as ferrous sulphate)
Experimental: Iron, Zinc and Vitamin A
Ferrous Sulphate, Zinc Sulphate and Vitamin A (10 mg/day of each zinc and iron, plus 1,000 IU vitamin A/day)
Zn+Fe+vit.A group received 10 mg/day of elemental zinc (as zinc sulphate) and 10 mg/day of elemental iron (as ferrous sulphate), plus 1,000 IU/day of vitamin A
Placebo Comparator: Placebo
No minerals/vitamin
Placebo group received no minerals/vitamin

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Length-for-Age Z-scores
Time Frame: Baseline and monthly thereafter until endline (6 month of intervention)
Length-for-Age Z-score
Baseline and monthly thereafter until endline (6 month of intervention)
Change in Weight-for-Length Z-scores
Time Frame: Baseline and monthly thereafter until endline (6 month of intervention)
Weight-for-Length Z-score
Baseline and monthly thereafter until endline (6 month of intervention)
Change in Weight-for-Age Z-scores
Time Frame: Baseline and monthly thereafter until endline (6 month of intervention)
Weight-for-Age Z-scores
Baseline and monthly thereafter until endline (6 month of intervention)
Changes in Mental Development Index
Time Frame: Baseline and Endline (6 month of intervention)
MDI of Bayley Scale of Infant Development II
Baseline and Endline (6 month of intervention)
Changes in Psychomotor Development Index
Time Frame: Baseline and Endline (6 month of intervention)
PDI of Bayley Scale of Infant Development II
Baseline and Endline (6 month of intervention)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in Hemoglobin
Time Frame: Baseline and Endline (6 month of intervention)
measured for all subjects (200 per group)
Baseline and Endline (6 month of intervention)
Changes in serum zinc
Time Frame: Baseline and Endline (6 month of intervention)
measured in sub-samples (65 subjects/group)
Baseline and Endline (6 month of intervention)
Changes in serum ferritin
Time Frame: Baseline and Endline (6 month of intervention)
measured in sub-samples (65 subjects/group)
Baseline and Endline (6 month of intervention)
Changes in serum retinol
Time Frame: Baseline and Endline (6 month of intervention)
measured in sub-samples (65 subjects/group)
Baseline and Endline (6 month of intervention)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Umi Fahmida, PhD, South East Asian Ministers of Education Organization, Regional Center for Food and Nutrition (SEAMEO-RECFON)

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 1998

Primary Completion (Actual)

February 1, 1999

Study Registration Dates

First Submitted

December 7, 2014

First Submitted That Met QC Criteria

December 13, 2014

First Posted (Estimate)

December 18, 2014

Study Record Updates

Last Update Posted (Estimate)

December 18, 2014

Last Update Submitted That Met QC Criteria

December 13, 2014

Last Verified

December 1, 2014

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Development

Clinical Trials on Zinc Alone

Subscribe